YAP in MAPK pathway targeted therapy resistance

Παρόμοια τεκμήρια

• RAS-MAPK in ALK targeted therapy resistance
  ανά: Hrustanovic, Gorjan, κ.ά.
  Έκδοση: (2015)
• The Hippo effector YAP regulates the response of cancer cells to MAPK pathway inhibitors
  ανά: Lin, Luping, κ.ά.
  Έκδοση: (2015)
• EGFR targeted therapy resistance: current status, challenges, and future outlook
  ανά: Bivona, Trever G.
  Έκδοση: (2020)
• Adaptive stress signaling in targeted therapy resistance in cancer
  ανά: Pazarentzos, Evangelos, κ.ά.
  Έκδοση: (2015)
• The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
  ανά: Lin, Luping, κ.ά.
  Έκδοση: (2015)